Save-the-date! Friday, November 14, 2014! The MOASC Oncology Summit will be held at the InterContinental Hotel in Century City.
The schedule is:
5:00pm Networking Reception - Exhibit Hall
6:30pm Dinner – Welcome & Introductions
7:00pm Keynote presentation Physician Hospital Partnerships: What they look like, Whether they work
and Should you consider one?
Lawrence D. Piro, M.D.
President & CEO, The Angeles Clinic
MOASC Board of Directors
Chair, MOASC Executive Committee
8:30pm Program concludes
For more information and to register, email email@example.com or call 909-985-9061 ext. 1.
This meeting precedes Research To Practice - Year In Review Program with Dr. Neil Love on
Saturday, November 15, 2014. For more information visit: www.researchtopractice.com
According to Noteware Government Relations, ANCO/MOASC advocates in Sacramento, the passage of SB809 requires physicians to register with the CURES system if they prescribe and/or dispense controlled substances effective January 1, 2016. However, they are not required to use the CURES system. Click here
for more information.
Noridian/JEMAC has posted the following updates to its website (http://med.noridianmedicare.com/web.jeb): Medicare B News JE November 2014--Now Available; Quarterly Update to CCI Edits, Version 21.1, Effective April 1, 2015; Feedback Requested--Noridian Customer Satisfaction Survey; MLN Connects Provider eNews (Videos--Monthly Spotlight: Physician Feedback Program.Value-based Payment Modifier; Announcements--CMS Releases New Proposal to Improve Accountable Care Organizations). Click here for more information.
Transaction Services is experiencing intermittent technical difficulties processing Computer Media Claim (CMC) transactions on the Medi-Cal website. As a result, providers and submitters checking Volser status may see the following message: “Submitter CMCSUBXXX, information about your Volser #XXXXX is not available. Please contact the CMC Helpdesk for information about this Volser.” Providers who receive this message should resubmit their files. Systems personnel are aware of the problem and are working on a resolution. Click here for more information.
ASCO, along with the AMA and other specialty societies, have launched a major grassroots initiative to urge Congress to take up Medicare physician payment reform legislation in the lame duck legislative session. You have the voice, and ASCO can be your megaphone to share your personal stories and expertise in cancer care with your Representative. Go to http://cqrcengage.com/asco/app/write-a-letter 0&engagementId=69837 to take action via the ACT Network and send a pre-drafted message to Congress. Click here for more information.
All eligible professionals participating in the Medicare EHR Incentive Program, are encouraged to join the next eHealth provider webinar tomorrow, December 17, from 10:00 a.m. to 11:00 a.m. Pacific Time for an overview of 2014 clinical quality measures (CQMs) and reporting options. CMS representatives will review the 2014 CQM Electronic Reporting Guide, which includes information about how to report 2014 CQMs electronically and options for reporting once in 2014 to earn credit for other Medicare quality reporting programs, including the Physician Quality Reporting System (PQRS) and Pioneer ACO programs. A portion of the webinar will be dedicated to Q&A. To learn more about CQMs, visit the Clinical Quality Measures webpage and the eCQM Library webpage. Space is limited. Register now to secure your spot for this eHealth Provider Webinar . Once your registration is complete, you will receive a follow-up email with step-by-step instructions on how to log-in to the webinar. Click here for more information.
Eli Lilly and Company announced that on November 5, 2014, the US Food and Drug Administration (FDA) approved a new indication for CYRAMZA® (ramucirumab). CYRAMZA as a single agent, or in combination with paclitaxel, is indicated for the treatment of patients with advanced or metastatic gastric or gastroesophageal junction adenocarcinoma with disease progression on or after priorfluoropyrimidine- or platinum-containing chemotherapy. With this new indication, CYRAMZA can now be used for treatment as a single agent, or in combination with chemotherapy. For more information, please visit www.CYRAMZAhcp.com. Please click here for full Prescribing Information, including Boxed Warning for hemorrhage.
Sargas Pharmaceutical Adherence and Compliance (SPAC) Internationalhas developed software and mobile applications to keep the physicians and patients engaged from the time a script is initiated through the entire treatment period. Please visit www.spacinternational.com to learn more. Click here to view the special offer for MOASC and ANCO members who enroll before December 31, 2014. This system can assist you in billing for Chronic Care Management as defined in the CMS CY 2015 Final Rule, https://www.spacinternational.com/pdf/4541_001.pdf. Click here for more information.
Medical Oncology Association of Southern California President's Letter
United We Stand
The practice of oncology is changing. The Medicare Modernization Act, Affordable Care Act, and sequestration have strained oncology practices to the breaking point. Oncologists are retiring without replacements. Practices are going out of business or bankrupted.
Oncologists are now confronted with rapidly changing contracting freedom. The proposed Anthem/Blue Cross Cancer Care Quality Program Treatment Pathwaysis the most recent fore by an insurer into controlling medical decisions via financial leverage.
Oncologists are fleeing to hospitals, Kaiser Permanente, and universities as a "safe haven." But, are they really safe? As those oncologists age, they will find themselves in an increasing "take it or leave it situation." Who will defend their employment and medical decision rights?
We at the Medical Oncology Association of Southern California (MOASC) want ALL oncologists to know that we will always stand beside you. MOASC and the Association of Northern California Oncologists (ANCO) have united and initiated the "Renewal Committee" to ask California oncologists, "What does today's oncologist want and need from its association?" MOASC and ANCO are committed to reformulate themselves to address the needs of all the current and future oncologists.
MOASC also continues its mission as your voice in State and Federal, insurance, and hospital matters. MOASC and ANCO fought, and won, its efforts to prevent MediCal from collecting years of past drug reimbursement, that MediCal arbitrarily and retroactively deemed "over-payments." MOASC is challenging the proposed Anthem/Blue Cross Cancer Care Quality Program Treatment Pathways. MOASC is part of the fight against the trial lawyers' attack on MICRA, Proposition 46. In his concluding act as MOASC President, my predecessor, Robert A. Moss, M.D., rebuts Proposition 45 in the 2014 California General Election Official Voter Information Guide. MOASC perseveres to protect oncologists' ability to provide unfettered patient care, prevent physician assisted suicide, and thwart over-regulation.
In these difficult times, I am asking you to stay united with your brethren through the Medical Oncology Association of Southern California. Help us stay politically strong. Help us help you. Join, or renew your membership in, MOASC. Get your colleagues to join as well. Together we can shape oncology in the future. Together we can dictate how we practice. Only physicians can provide medical care; only we can cut ourselves out of the decision making through apathy and fragmentation. United we stand; divide we fall.
Warren Fong, M.D.
MOASC's final program for 2014, The MOASC Oncology Summit, was held on November 14th at the InterContinental Hotel in Century City. The program was sponsored, in part, by: McKesson, Pfizer, Myriad, Axess Oncology and Alexion. The day started with the MOASC Board of Directors and Industry partners discussing new and various ways of continued collaboration to preserve, and grow, access to oncology care in southern California. Throughout the afternoon, MOASC physicians attended the numerous Advisory Boards made available to them. Following the Advisory Boards, MOASC members met in the Exhibit Hall for refreshments and lively exchange of ideas from the afternoon's meetings. The keynote presentation, "Physician-Hospital Relationships: Really...We're Going Here Again?" was presented by Lawrence D. Piro, M.D., President & CEO, The Angeles Clinic, and member of MOASC Board of Directors. MOASC's new president, Dr. Warren Fong, was introduced by outgoing president, Dr. Robert Moss. Dr. Fong presented Dr. Moss with a crystal gavel as a token of appreciation of his years of service. Ann Womack was also recognized and presented with a gift for her years of service as the Administrator Vice President.
We hope to see you at our forthcoming programs in 2015!
The MOASC Administrator Program was held on October 22nd at the Disneyland Hotel in Anaheim.
The first presentation was “Alignment with a hospital: Should I stay or should I go?” Presented by: Teri U. Guidi, MBA, FAAMA,President & CEO, Oncology Management Consulting Group. The second presentation was “Patient Satisfaction surveys for PQRS & Meaningful Use” Presented by: Thomas P. Jeffrey, President, SullivanLuallin Group The third presentation was “Automation developed by Sargas HIPPA compliant cloud applications and Sargas mHealth makes Chronic Care Management (CCM) feasible, scalable and sustainable” Presented by: Gitesh Patel, Chief Executive Officer, Sargas Pharmaceutical Adherence & Compliance (SPAC) International LLC. The fourth presentation was “Targeted Pure Supplements in Oncology-Revenue and Implementation Model”Presented by: Sreenivas Rao, M.D., President, OncoQol. After lunch, Dawn Holcombe, President of DGH Consulting, and Willis Triplett, Pharm D. Corporate Pharmacy Specialist at HQAA, discussed “USP and Other Major Issues for Oncology: Strategy, Awareness, and Options.” This program was sponsored in part by the following: Merck, Genentech, McKesson, Dendreon, OncoQol, MJ Executive Management on behalf of SayAh, Boehringer-Ingelheim and American Regent.
For a copy of the handouts, please send an email to firstname.lastname@example.org
The MOASC Clinical Staff Program was held on September 19th in Pasadena.
The first presentation was "Oral Adherence”Presented by:Flora Woo, MSN, RN, Senior Clinical Nurse Consultant, Celgene Corporation. The second presentation was "Compassion Fatigue: Building Resilience in Oncology Nurses”Presented by: Katherine Joyce Janzen RN, MN, ONC(C), Assistant Professor, School of Nursing and Midwifery; Faculty of Health and Community Studies, Mount Royal University, Calgary, Alberta, Canada. The third presentation was “The Art of Active Listening”Presented by:Selinza Ann Mitchell, CNS, Oncology Clinical Nurse Educator. This program was sponsored in part by the following: Celgene, Pfizer, McKesson, Millennium, Eisai, Merck, Genentech, OncoQol, American Regent, and Foundation Medicine.
For a copy of the handouts, please send an email to email@example.com
Thank you to the following sponsors for assisting MOASC in achieving their mission.